MannKind Corporation To Hold Fourth Quarter Financial Results Conference Call On February 6, 2006

VALENCIA, Calif., Jan. 30 /PRNewswire-FirstCall/ -- MannKind Corporation will release its 2005 fourth quarter financial results on Monday, February 6, 2006 at 8:30 a.m. ET.

Management of the Company will host a conference call to discuss the fourth quarter financial results, clinical progress and other Company developments at 9:00 a.m. ET on Monday, February 6, 2006. Presenting from the Company will be its Chairman and Chief Executive Officer, Alfred Mann; President and Chief Operating Officer, Hakan Edstrom; and Corporate Vice President and Chief Financial Officer, Dick Anderson.

To participate in the live call by telephone, please dial (888) 566-5775 or (210) 839-8503. Those interested in listening to the conference call live via the Internet may do so by visiting the Company's website at www.mannkindcorp.com.

A telephone replay of the call will be available for 48 hours by dialing (866) 350-6999 or (203) 369-0042 and entering conference number 1437837. A replay will be available on MannKind's website for fourteen days.

About MannKind Corporation

MannKind Corporation focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Its lead product, the Technosphere(R) Insulin System, is currently in phase 3 clinical trials in the U.S. and Europe to study its safety and efficacy in the treatment of diabetes. For more information on MannKind Corporation and its technology, visit www.mannkindcorp.com.

MannKind Corporation

CONTACT: Dick Anderson, Chief Financial Officer of MannKind Corporation,+1-661-775-5302, danderson@mannkindcorp.com; or Investors, Julie Huang ofFinancial Dynamics, +1-212-850-5628, Julie.Huang@fd.com, for MannKindCorporation

Back to news